OHSU, Ionis Pharmaceuticals to develop drugs for ‘undruggable’ cancer targets

Collaboration aims to expedite discoveries for patients with leukemia

By Amanda Gibbs January 27, 2020 Portland, Oregon

Downloads

Jeff Tyner, Ph.D. (2018)

Jeff Tyner, Ph.D., associate professor in the OHSU School of Medicine department of Cell, Developmental & Cancer Biology and researcher with the OHSU Knight Cancer Institute, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeff Tyner, Ph.D. (2018)